Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Impact of depression, fatigue, and global measure of cortical volume on cognitive impairment in multiple sclerosis.
Restless leg syndrome and multiple sclerosis: a case-control study in China.
Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis.
Heterogeneous spectrum of neuropathies in Waldenström's macroglobulinemia: a diagnostic strategy to optimize their management.
Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.
Intramuscular IFNß-1a in multiple sclerosis: 'no proof of effectiveness' or 'proof of no effectiveness'?
Phosphodiesterase-5 inhibition promotes remyelination by MCP-1/CCR-2 and MMP-9 regulation in a cuprizone-induced demyelination model.
Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients.
Sphingosine kinase inhibition ameliorates chronic hypoperfusion-induced white matter lesions.
The astrocyte in multiple sclerosis revisited.
Comprehensive Review of Ocular Angiostrongyliasis with Special Reference to Optic Neuritis.
MULTIPLE SCLEROSIS IN CHILDHOOD.
Exogenous Adult Post Mortem Neural Precursors attenuate secondary degeneration, and promote myelin sparing and functional recovery following experimental spinal cord injury.
Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 children.
[Thoughts on hot issues of neuromyelitis optica].
[Association between Multiple Sclerosis or Neuromyelitis Optica and Epstein-Barr Virus].
Serum complement factor and Tyr4O2 His gene polymorphism among Egyptians with multiple sclerosis.
Evidence for Borna disease virus infection in neuropsychiatric patients in three western China provinces.
Novel therapeutic options for multiple sclerosis.
Genome-wide significant association with seven novel multiple sclerosis risk loci.
A systems pharmacology approach to decipher the mechanism of danggui-shaoyao-san decoction for the treatment of neurodegenerative diseases.
A proposed dosing algorithm for the individualized dosing of human immunoglobulin in chronic inflammatory neuropathies.
A retrospective case series of pediatric spinal cord injury and disease in Victoria, Australia.
Progressive Multifocal Leukoencephalopathy.
Effect of Bushen Yisui Capsule () on oligodendrocyte lineage genes 1 and 2 in mice with experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
656
657
658
659
660
661
662
663
664
…
next ›
last »